HK1091806A1 - Antihistaminic piperidine derivatives and intermediates for the preparation thereof - Google Patents

Antihistaminic piperidine derivatives and intermediates for the preparation thereof

Info

Publication number
HK1091806A1
HK1091806A1 HK06112043.6A HK06112043A HK1091806A1 HK 1091806 A1 HK1091806 A1 HK 1091806A1 HK 06112043 A HK06112043 A HK 06112043A HK 1091806 A1 HK1091806 A1 HK 1091806A1
Authority
HK
Hong Kong
Prior art keywords
intermediates
preparation
piperidine derivatives
antihistaminic piperidine
antihistaminic
Prior art date
Application number
HK06112043.6A
Other languages
English (en)
Inventor
Timothy A Ayers
Paul W Brown
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22328222&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1091806(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of HK1091806A1 publication Critical patent/HK1091806A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/90—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated
    • C07C233/91—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated with carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK06112043.6A 1998-07-02 2006-11-01 Antihistaminic piperidine derivatives and intermediates for the preparation thereof HK1091806A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10954298A 1998-07-02 1998-07-02

Publications (1)

Publication Number Publication Date
HK1091806A1 true HK1091806A1 (en) 2007-01-26

Family

ID=22328222

Family Applications (3)

Application Number Title Priority Date Filing Date
HK01102844.3A HK1034065A1 (en) 1998-07-02 2001-04-23 Antihistaminic piperidine derivatives and intermediates for the preparation thereof
HK06112043.6A HK1091806A1 (en) 1998-07-02 2006-11-01 Antihistaminic piperidine derivatives and intermediates for the preparation thereof
HK09104335.7A HK1125382A1 (en) 1998-07-02 2009-05-12 Antihistaminic piperidine derivatives and intermediates for the preparation thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK01102844.3A HK1034065A1 (en) 1998-07-02 2001-04-23 Antihistaminic piperidine derivatives and intermediates for the preparation thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK09104335.7A HK1125382A1 (en) 1998-07-02 2009-05-12 Antihistaminic piperidine derivatives and intermediates for the preparation thereof

Country Status (21)

Country Link
EP (1) EP1091938B1 (xx)
JP (1) JP2002519411A (xx)
KR (2) KR100707904B1 (xx)
CN (3) CN100522921C (xx)
AR (1) AR019197A1 (xx)
AT (1) ATE485271T1 (xx)
AU (1) AU769284B2 (xx)
BR (1) BR9911794A (xx)
CA (1) CA2336380C (xx)
DE (1) DE69942876D1 (xx)
DK (1) DK1091938T3 (xx)
ES (1) ES2354968T3 (xx)
HK (3) HK1034065A1 (xx)
HU (1) HUP0104159A3 (xx)
IL (6) IL140649A0 (xx)
NO (1) NO319534B1 (xx)
NZ (2) NZ528839A (xx)
PT (1) PT1091938E (xx)
TW (1) TW533197B (xx)
WO (1) WO2000001671A2 (xx)
ZA (1) ZA200007034B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003104197A1 (en) 2002-06-10 2003-12-18 Teva Pharmaceutical Industries Ltd. Polymorphic form xvi of fexofenadine hydrochloride
CN101585768B (zh) * 2009-06-06 2012-01-04 浙江大学宁波理工学院 合成2-[4-(4-氯丁酰基)苯基]-2-甲基丙酸酯的方法
CN101585767B (zh) * 2009-06-06 2012-02-15 浙江大学宁波理工学院 一种合成2—[4—(4—氯丁酰基)苯基]—2—甲基丙酸酯的方法
CN101585764B (zh) * 2009-06-06 2012-02-15 浙江大学宁波理工学院 合成2—［4—(4—氯丁酰基)苯基］—2—甲基丙酸的方法
CN101585763B (zh) * 2009-06-06 2012-01-04 浙江大学宁波理工学院 一种合成2-[4-(4-氯丁酰基)苯基]-2-甲基丙酸的方法
EP2289867A3 (en) * 2009-08-19 2012-04-25 Jubilant Organosys Limited A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof
JP6192554B2 (ja) * 2014-02-03 2017-09-06 三菱電機株式会社 真空断熱材の製造方法
CN112661693A (zh) * 2021-01-27 2021-04-16 西北农林科技大学 一种非索非那定的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839431A (en) * 1970-07-13 1974-10-01 Squibb & Sons Inc Cyclopropylmethylphenylacetic acids and derivatives
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
MX9302076A (es) * 1992-04-10 1994-03-31 Merrell Dow Pharma Proceso novedoso para preparar derivados de piperidina.
US5654433A (en) * 1993-01-26 1997-08-05 Merrell Pharmaceuticals Inc. Process for piperidine derivatives
WO1995000482A1 (en) * 1993-06-24 1995-01-05 Albany Molecular Research, Inc. Piperidine derivatives and process for their production
CN1159277C (zh) * 1993-06-25 2004-07-28 默里尔药物公司 用于制备抗组胺哌啶衍生物的新中间体
KR19990008406A (ko) * 1995-05-08 1999-01-25 스티븐엘.네스비트 알파-(치환된 알킬페닐)-4-(히드록시디페닐메틸)-1-피페리딘 부탄올 유도체들, 그들의 제조 방법 및 항히스타민제, 항알러지제및 기관지 확장제로서 그들의 용도

Also Published As

Publication number Publication date
BR9911794A (pt) 2001-03-27
NO319534B1 (no) 2005-08-29
ATE485271T1 (de) 2010-11-15
IL140649A (en) 2006-08-01
CN101311165A (zh) 2008-11-26
CN101311165B (zh) 2011-05-18
DK1091938T3 (da) 2011-02-07
EP1091938A2 (en) 2001-04-18
HUP0104159A2 (hu) 2002-03-28
IL171063A (en) 2007-09-20
IL171061A (en) 2007-09-20
JP2002519411A (ja) 2002-07-02
AR019197A1 (es) 2001-12-26
CN1308611A (zh) 2001-08-15
ZA200007034B (en) 2002-04-08
ES2354968T3 (es) 2011-03-21
HUP0104159A3 (en) 2002-04-29
EP1091938B1 (en) 2010-10-20
DE69942876D1 (de) 2010-12-02
KR100707904B1 (ko) 2007-04-16
IL171062A (en) 2007-09-20
NO20006694D0 (no) 2000-12-29
AU4574699A (en) 2000-01-24
IL140649A0 (en) 2002-02-10
CN100522921C (zh) 2009-08-05
AU769284B2 (en) 2004-01-22
KR20060035816A (ko) 2006-04-26
CA2336380C (en) 2007-04-10
HK1034065A1 (en) 2001-10-12
CA2336380A1 (en) 2000-01-13
CN1246312C (zh) 2006-03-22
CN1807394A (zh) 2006-07-26
IL171479A (en) 2007-10-31
KR100682447B1 (ko) 2007-02-16
NZ528839A (en) 2005-03-24
HK1125382A1 (en) 2009-08-07
WO2000001671A3 (en) 2000-04-06
WO2000001671A2 (en) 2000-01-13
NZ508477A (en) 2003-12-19
TW533197B (en) 2003-05-21
KR20010053324A (ko) 2001-06-25
NO20006694L (no) 2001-03-01
PT1091938E (pt) 2010-12-20

Similar Documents

Publication Publication Date Title
AU2942000A (en) Novel piperidine derivatives
EG23817A (en) 4-Phenyl-pyridine derivatives
ZA9811345B (en) Piperidine derivatives
GC0000183A (en) 3-Phenyl-pyridine derivatives
HK1125382A1 (en) Antihistaminic piperidine derivatives and intermediates for the preparation thereof
HK1046400A1 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives
IL149584A0 (en) New phenalkyloxy-phenyl derivatives
ZA992191B (en) Piperidine derivatives.
EG23070A (en) Novel propargylether derivatives
ZA952431B (en) New piperidine derivatives
IL146629A0 (en) Indolylpiperidine derivatives as antihistaminic and antiallergic agents
GC0000191A (en) 4-Phenyl-pyrimidine derivatives
IL123860A0 (en) Phenoxymethyl piperidine derivatives
HUP0204217A3 (en) Novel a-500359 derivatives
HU9900275D0 (en) Pyrrolidine and piperidine derivatives
GB9925880D0 (en) B-Carboline derivatives
EG26101A (en) Derivatives of ethane sulfonyl - piperidine
EP1229913A4 (en) SUBSTITUTED 1-BENZAZEPINE AND THEIR DERIVATIVES
SG71062A1 (en) 4-Hydroxy piperidine derivatives
AP2001002327A0 (en) 1-Trifluoromethyl-4-hydroxy-7- piperidinylaminomethy lchroman derivatives
AU7557000A (en) Piperidine derivatives
ZA972329B (en) Piperidine derivatives
ZA97329B (en) Piperidine or tetrahydropyridine derivatives
AU2003268868B8 (en) Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
AU9462098A (en) Piperidine derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180617